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Abstract
Background and purpose of the study: Acenaphtho derivatives have been reported as antitumor agents. Due to
this fact and also with the aim of developing the chemistry of potentially bioactive heterocyclic compounds via efficient
reactions, a facile procedure for the synthesis of 9-(alkylthio)-acenaphtho[1,2-e]-1,2,4-triazines via two step condensation
of thiosemicarbazide and acenaphtylene-9,10-quinone to form acenaphtho[1,2-e]-1,2,4-triazine-9(8H)-thiones and
subsequent reaction with benzyl chloride derivatives is reported.
Methods: 9-(alkylthio) acenaphtho[1,2-e]-1,2,4-triazines were synthesized via the reaction of acenaphtho-9,10-quinone
with thiosemicarbazide, and then with the benzyl chloride derivatives. Cytotoxicity of some prepared compounds was
assessed through MTT assay on three different human cancerous cell lines (HL-60, MCF7, and MOLT-4 cells). Molecular
docking studies were performed via AutoDock4.2 software in order to confirm an apoptosis-inducing activity of
acenaphtho scaffolds via the Bcl-2 protein.
Results: Excellent yields of the products, short reaction times and simple work-up are attractive features of this
synthetic protocol. The evaluated compounds exhibited moderate to good cytotoxic activities. Docking results
on the active site of B-cell lymphoma 2 (Bcl-2) supported the experimental biological data and agreed well with
previous in silico data for commonly used anti-cancer drugs. Moreover; results were analyzed considering binding
efficiency indices.
Conclusions: The outcomes of the present study may be helpful in future targeting of Bcl-2 with the aim of
developing apoptosis-inducing agents.
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Introduction
Economic generation of bioactive compounds has been
a major concern in modern organic chemistry [1]. In this
regard, development of novel compounds and especially
diverse small molecule scaffolds caused higher attention
of medicinal and biological chemists [2-4]. This can be
attributed to the growing requirement in assembling
libraries of structurally complex substances to be evalu-
ated as hit/lead compounds in drug discovery projects.
Polycyclic aromatic hydrocarbon (PAH) heterocycles are
highly important structural units in a variety of pharmaco-
logically active substances [5-9]. At first glance, rigid poly-
cyclic structures seem to have role in the development of
antitumor agents owing to their ability in insertion be-
tween stacked base pairs of oligonucleotides and action as
intercalator [10-12]. Particularly important is that when
these planar polycyclic heterocycles bear appropriate side
chains, further interactions with other important macro-
molecules might be envisaged [11,13].
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